CLA (CliftonLarsonAllen) Wealth Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,885
Closed -$435K 139
2022
Q2
$435K Sell
12,885
-3,014
-19% -$106K 0.02% 166
2022
Q1
$555K Sell
15,899
-95
-0.6% -$3.25K 0.02% 170
2021
Q4
$487K Sell
15,994
-117
-0.7% -$3.81K 0.02% 162
2021
Q3
$528K Buy
16,111
+2,953
+22% +$94.5K 0.02% 216
2021
Q2
$398K Buy
+13,158
New +$433K 0.02% 254

Other funds holding OGN

CLA (CliftonLarsonAllen) Wealth Advisors's OGN Position: Q3 2022 in Review

CLA (CliftonLarsonAllen) Wealth Advisors sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 12,885 shares — an estimated $435K sold.

CLA (CliftonLarsonAllen) Wealth Advisors first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $555K in Q1 2022. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • CLA (CliftonLarsonAllen) Wealth Advisors reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • CLA (CliftonLarsonAllen) Wealth Advisors sold 12,885 Organon & Co shares in Q3 2022, an estimated $435K.
  • CLA (CliftonLarsonAllen) Wealth Advisors first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • CLA (CliftonLarsonAllen) Wealth Advisors's Organon & Co position peaked at $555K in Q1 2022.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on CLA (CliftonLarsonAllen) Wealth Advisors's 13F filing for Q3 2022, filed 12 Oct 2022.